Current NDC auxiliary source row compounder:600

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 73198-177
Product Ndc: 73198-177
Product Ndc Digits: 73198177
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Niagen
Proprietary Name Suffix: [empty]
Nonproprietary Name: Nicotinamide riboside chloride 100 mg/mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Olympia Pharmacy
Establishment Name: Olympia Pharmacy
Establishment Fei: [empty]
Substance Name: NICOTINAMIDE RIBOSIDE CHLORIDE
Active Ingredients Info: 87.8053 mg/1 mL
History Active Ingredients Raw: NICOTINAMIDE RIBOSIDE CHLORIDE
History Active Ingredients Info Raw: 87.8053 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 73198-177-05
Package Ndc: 73198-177-05
Package Ndc Digits: 7319817705
Package Ndc11: 73198017705
Package Description: 5 mL in 1 VIAL, MULTI-DOSE (73198-177-05)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:600
Source Row Number: 600
Source Row Hash: 8d2e74966476b526ee2d0a893ca33cab42e8ab84b3eeaa76418474b980c9c3fa
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS",
    "PRODUCTNDC": "73198-177",
    "DEASCHEDULE": "",
    "LABELERNAME": "Olympia Pharmacy",
    "SUBSTANCENAME": "NICOTINAMIDE RIBOSIDE CHLORIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "73198-177-05",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Niagen",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Nicotinamide riboside chloride 100 mg/mL",
    "PACKAGEDESCRIPTION": "5 mL in 1 VIAL, MULTI-DOSE (73198-177-05) ",
    "ACTIVEINGREDIENTSINFO": "87.8053 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:600
Source Row Number: 600
Status Scope: package
Lookup Ndc: 73198-177-05
Lookup Ndc Digits: 7319817705
Product Ndc: 73198-177
Product Ndc Digits: 73198177
Package Ndc: 73198-177-05
Package Ndc Digits: 7319817705
Package Ndc11: 73198017705
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 8d2e74966476b526ee2d0a893ca33cab42e8ab84b3eeaa76418474b980c9c3fa
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20